Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

80 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A Systematic Review of Patient Engagement Experiences in Brain Disorders.
Bertorello D, Brichetto G, Folkvord F, Theben A, Zaratin P. Bertorello D, et al. Among authors: zaratin p. Patient Relat Outcome Meas. 2022 Dec 13;13:259-272. doi: 10.2147/PROM.S256396. eCollection 2022. Patient Relat Outcome Meas. 2022. PMID: 36536754 Free PMC article. Review.
Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis.
Sormani MP, De Rossi N, Schiavetti I, Carmisciano L, Cordioli C, Moiola L, Radaelli M, Immovilli P, Capobianco M, Trojano M, Zaratin P, Tedeschi G, Comi G, Battaglia MA, Patti F, Salvetti M; Musc-19 Study Group. Sormani MP, et al. Among authors: zaratin p. Ann Neurol. 2021 Apr;89(4):780-789. doi: 10.1002/ana.26028. Epub 2021 Feb 9. Ann Neurol. 2021. PMID: 33480077 Free PMC article.
Researching COVID-19 in progressive MS requires a globally coordinated, multi-disciplinary and multi-stakeholder approach-perspectives from the International Progressive MS Alliance.
Zaratin P, Banwell B, Coetzee T, Comi G, Feinstein A, Hyde R, Salvetti M, Smith K. Zaratin P, et al. Mult Scler J Exp Transl Clin. 2022 May 3;8(2):20552173221099181. doi: 10.1177/20552173221099181. eCollection 2022 Apr-Jun. Mult Scler J Exp Transl Clin. 2022. PMID: 35530174 Free PMC article.
The agenda of the global patient reported outcomes for multiple sclerosis (PROMS) initiative: Progresses and open questions.
Zaratin P, Vermersch P, Amato MP, Brichetto G, Coetzee T, Cutter G, Edan G, Giovannoni G, Gray E, Hartung HP, Hobart J, Helme A, Hyde R, Khan U, Leocani L, Mantovani LG, McBurney R, Montalban X, Penner IK, Uitdehaag BMJ, Valentine P, Weiland H, Bertorello D, Battaglia MA, Baneke P, Comi G; PROMS Initiative Working Groups. Zaratin P, et al. Mult Scler Relat Disord. 2022 May;61:103757. doi: 10.1016/j.msard.2022.103757. Epub 2022 Mar 23. Mult Scler Relat Disord. 2022. PMID: 35367873 Free article.
Charting a global research strategy for progressive MS-An international progressive MS Alliance proposal.
Thompson AJ, Carroll W, Ciccarelli O, Comi G, Cross A, Donnelly A, Feinstein A, Fox RJ, Helme A, Hohlfeld R, Hyde R, Kanellis P, Landsman D, Lubetzki C, Marrie RA, Morahan J, Montalban X, Musch B, Rawlings S, Salvetti M, Sellebjerg F, Sincock C, Smith KE, Strum J, Zaratin P, Coetzee T. Thompson AJ, et al. Among authors: zaratin p. Mult Scler. 2022 Jan;28(1):16-28. doi: 10.1177/13524585211059766. Epub 2021 Dec 1. Mult Scler. 2022. PMID: 34850641 Free PMC article. Review.
80 results